Mehdi Maghsoodnia's guest appearances

Mehdi Maghsoodnia

Empowered Patient Podcast

Just Go Grind with Justin Gordon

FESTWORLD Radio

From Lab to Launch by Qualio

Elon Musk

Bill Gates

Tim Ferriss

Jack Hughes

Mikey Taylor

Gary Arndt

Omar Zenhom

Justin Martin

Chris Lee

Jennifer Smith

Andrew Parker

John Lee Dumas

Austin Belcak

Sam Adams

Vanessa Larco

OwlTail

Mehdi Maghsoodnia is the CEO of 1health and is determined to bring advanced diagnostic medical tests to a broader audience to enable more patients to benefit from precision medicine advancements. Too often, patients are put on costly drugs that are not effective. Using data from advanced testing allows clinicians to diagnose conditions more accurately and to determine the best treatment approach. Mehdi elaborates, "Where we focus is really more on how do we make these advanced diagnostic tests cheaper and faster, so we can introduce more accurate, clean data into that care pathway. You want to know very quickly, very accurately, all that you need to know about the specifics of the patient, the specifics of their genetics, and the specifics of the potential tumor type, interaction with drugs, and so on and so forth. Those are the types of information we are trying to deliver into the care decision pathway very quickly." "That data set is building up very rapidly because we've been sequencing patients, and we've been tracking the impact of the drug on those patients. Now, those databases are coming to the clinical market. They're not there today everywhere, so unfortunately, you might get the best pharmacogenomic results in some of the advanced institutions in urban areas, like San Francisco and New York, but you don't get it everywhere." "Part of our push on the pharmacogenomic side is to make sure that it's available and accessible by everybody. Health equity is a big issue right now. We are making sure that the test is not only affordable, but it's easy to order, and it's easy to include in the healthcare pathway for every patient at every point in the care system." @ihealthio #1health #PrecisionMedicine #AdvancedDiagnostics #DiagnosticTesting #CancerDetection #Pharmacogenomic 1health.io Download the transcript here

Mehdi Maghsoodnia is the CEO of 1health and is determined to bring advanced diagnostic medical tests to a broader audience to enable more patients to benefit from precision medicine advancements. Too often, patients are put on costly drugs that are not effective. Using data from advanced testing allows clinicians to diagnose conditions more accurately and to determine the best treatment approach. Mehdi elaborates, "Where we focus is really more on how do we make these advanced diagnostic tests cheaper and faster, so we can introduce more accurate, clean data into that care pathway. You want to know very quickly, very accurately, all that you need to know about the specifics of the patient, the specifics of their genetics, and the specifics of the potential tumor type, interaction with drugs, and so on and so forth. Those are the types of information we are trying to deliver into the care decision pathway very quickly." "That data set is building up very rapidly because we've been sequencing patients, and we've been tracking the impact of the drug on those patients. Now, those databases are coming to the clinical market. They're not there today everywhere, so unfortunately, you might get the best pharmacogenomic results in some of the advanced institutions in urban areas, like San Francisco and New York, but you don't get it everywhere." "Part of our push on the pharmacogenomic side is to make sure that it's available and accessible by everybody. Health equity is a big issue right now. We are making sure that the test is not only affordable, but it's easy to order, and it's easy to include in the healthcare pathway for every patient at every point in the care system." @ihealthio #1health #PrecisionMedicine #AdvancedDiagnostics #DiagnosticTesting #CancerDetection #Pharmacogenomic <a href="http://1health.io" rel="noopener nofollow" target="_blank">1health.io</a> <a href="http://empoweredpatientradio.com/precision-medicine-requires-more-accessible-and-affordable-advanced-diagnostics-with-mehdi-maghsoodnia-1health-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Precision Medicine Requires  More Accessible and Affordable Advanced Diagnostics with Mehdi Maghsoodnia 1health

 Mehdi Maghsoodnia is the CEO of 1health, the leading testing as a service (TaaS) company. He is passionate about personalized healthcare and increasing access to testing in the U.S.     1health launched TaaS earlier this year by bringing to market the first FDA Emergency Use Authorized COVID-19 saliva test, in partnership with IBX (Previously RUCDR). Through these at-home saliva tests, 1health is responsible for the deployment of 1% of COVID-19 testing across the United States.    Instead of asking people to go get tested in laboratories that are often crowded and have delayed results, Mehdi is driving his businesses to bring affordable, simple testing to the people, wherever they are. 1health partners with hospital systems, telehealth companies, corporations and government agencies, school systems, consumer brands, as well as public health departments around the country. Through its lab network, centralized platform, and health partnerships, now more than seven million Americans have access to the 1health COVID-19 saliva test.    Mehdi is on the board of SpineZone and MedCorder, and previously served as CEO of Rafter, BookRenter.com, SVP of products at CafePress, COO at Actiance and SVP at Intellisync. He is also an industry fellow at UC Berkeley, where he teaches innovation and entrepreneurship. He holds a Master’s of Science in EECS from Stanford, and a Bachelor of Science from UC Berkeley.  Some of the Topics Covered by Mehdi Maghsoodnia in this Episode    What 1health is doing and how it got started Why Mehdi chose to work on this particular problem and get involved in the healthcare industry What the initial product at 1health consisted of How Mehdi funding 1health Mehdi's thoughts around building a team Acquiring customers for 1health and how Mehdi looks at testing different channels How Mehdi thinks about pricing and GTM strategy The competitive landscape 1health is operating in Educating the market when you're creating a whole new market The ideal customer for 1health today Mehdi's experience investing in companies and some of the things he's looking for in companies he invests in How Vitagene came about from 1health What Mehdi's schedule looks like today Learning to say no and how to delegate The magic of exercise to improve your thinking    Sign up for The Weekly Grind, for actionable insights and stories from successful entrepreneurs delivered to your inbox once per week: https://www.justgogrind.com/newsletter/ Listen to all episodes of the Just Go Grind Podcast: https://www.justgogrind.com/podcast/ Follow Justin Gordon on Twitter: https://twitter.com/justingordon212 Follow Justin Gordon on Instagram: https://www.instagram.com/justingordon8/

Mehdi Maghsoodnia is the CEO of <a href="http://1health.io/" rel="noreferrer noopener nofollow" target="_blank">1health</a>, the leading testing as a service (TaaS) company. He is passionate about personalized healthcare and increasing access to testing in the U.S.  <a href="http://1health.io/" rel="noreferrer noopener nofollow" target="_blank">1health</a> launched TaaS earlier this year by bringing to market the first FDA Emergency Use Authorized COVID-19 saliva test, in partnership with IBX (Previously RUCDR). Through these at-home saliva tests, <a href="http://1health.io/" rel="noreferrer noopener nofollow" target="_blank">1health</a> is responsible for the deployment of 1% of COVID-19 testing across the United States.  Instead of asking people to go get tested in laboratories that are often crowded and have delayed results, Mehdi is driving his businesses to bring affordable, simple testing to the people, wherever they are. <a href="http://1health.io/" rel="noreferrer noopener nofollow" target="_blank">1health</a> partners with hospital systems, telehealth companies, corporations and government agencies, school systems, consumer brands, as well as public health departments around the country. Through its lab network, centralized platform, and health partnerships, now more than seven million Americans have access to the <a href="http://1health.io/" rel="noreferrer noopener nofollow" target="_blank">1health</a> COVID-19 saliva test.  Mehdi is on the board of SpineZone and MedCorder, and previously served as CEO of Rafter, <a href="http://bookrenter.com/" rel="noreferrer noopener nofollow" target="_blank">BookRenter.com</a>, SVP of products at CafePress, COO at Actiance and SVP at Intellisync. He is also an industry fellow at UC Berkeley, where he teaches innovation and entrepreneurship. He holds a Master’s of Science in EECS from Stanford, and a Bachelor of Science from UC Berkeley. Some of the Topics Covered by Mehdi Maghsoodnia in this Episode <ul> <li>What 1health is doing and how it got started</li> <li>Why Mehdi chose to work on this particular problem and get involved in the healthcare industry</li> <li>What the initial product at 1health consisted of</li> <li>How Mehdi funding 1health</li> <li>Mehdi's thoughts around building a team</li> <li>Acquiring customers for 1health and how Mehdi looks at testing different channels</li> <li>How Mehdi thinks about pricing and GTM strategy</li> <li>The competitive landscape 1health is operating in</li> <li>Educating the market when you're creating a whole new market</li> <li>The ideal customer for 1health today</li> <li>Mehdi's experience investing in companies and some of the things he's looking for in companies he invests in</li> <li>How Vitagene came about from 1health</li> <li>What Mehdi's schedule looks like today</li> <li>Learning to say no and how to delegate</li> <li>The magic of exercise to improve your thinking</li> </ul> Sign up for The Weekly Grind, for actionable insights and stories from successful entrepreneurs delivered to your inbox once per week: <a href="https://www.youtube.com/redirect?v=qgLzW3af2GM&amp;event=video_description&amp;redir_token=QUFFLUhqbURDaXp6XzVLZWdjNldjYUtSekhGWjRzRVJYUXxBQ3Jtc0trUVJ2aEZGV2xob1NaZ3MtOGMtbC1vYlZpbnhOWW8yZlpUdjVvQXl3YWtEVVNnWnBJZ28zZUhxeVFHSkZfb2R6aGlnUHVwQ25MbWdHbzBIaFNVZHFabUhGNGVaOF9WZnptN2ZIQU9TOGoxYmF1aGYzVQ%3D%3D&amp;q=https%3A%2F%2Fwww.justgogrind.com%2Fnewsletter%2F" rel="nofollow noopener" target="_blank">https://www.justgogrind.com/newsletter/</a> Listen to all episodes of the Just Go Grind Podcast: <a href="https://www.youtube.com/redirect?v=qgLzW3af2GM&amp;event=video_description&amp;redir_token=QUFFLUhqbHk1UzBzQ0VMcXZYUXFkbTQ3WHFES0dWUlNpd3xBQ3Jtc0ttc09EMlM4dkNoNHFkSTIwcWFOUWhyVEVGU2h0XzNYZHdrWjNCaHVSR2NBR1FFUU94Q1hNbTVaSXJlX1VPelctVzB1LW1RdDlTNVhibEJyem9nZVloaW5qYURKQkR2Vzl5eGc2Um5aUnNLLTVpWWxaTQ%3D%3D&amp;q=https%3A%2F%2Fwww.justgogrind.com%2Fpodcast%2F" rel="nofollow noopener" target="_blank">https://www.justgogrind.com/podcast/</a> Follow Justin Gordon on Twitter: <a href="https://www.youtube.com/redirect?v=qgLzW3af2GM&amp;event=video_description&amp;redir_token=QUFFLUhqbVZ0ZU16T0JGSTFUUUdrQUt2UFVVUEFQa3VxQXxBQ3Jtc0tua2p4ZkRvU3Z3LUR5Zmh0cGZOUVVMbWU2QS1ib1luaXBoWG1aN29vbmNrTHFBMW5iMXdWeXVQeDlOajBLOUhRX01TdDlCNWJ6OXB3bFFPanJPS2VCVXBlamowQm1mQVJ5X1M2ZlpNRHdoNkxhbUtlZw%3D%3D&amp;q=https%3A%2F%2Ftwitter.com%2Fjustingordon212" rel="nofollow noopener" target="_blank">https://twitter.com/justingordon212</a> Follow Justin Gordon on Instagram: <a href="https://www.youtube.com/redirect?v=qgLzW3af2GM&amp;event=video_description&amp;redir_token=QUFFLUhqbWlnRHNLNGRna1ZKaE9FbFNRcmdUQ2JmdnE5Z3xBQ3Jtc0tuZTk1SEdNZVpCZS1fTWJQNEZlaUtQOWFlOHd2eTdYTHBKZU5sWDVtSWYxQ3NLMjNlcGM3YWN1UjA3b2xHU2dsQjZuWVQ2cmxldjBSbTFPLVc5akY5clFkUDlSQ0RUTERrczM1VVcyUTctSm02OFpMOA%3D%3D&amp;q=https%3A%2F%2Fwww.instagram.com%2Fjustingordon8%2F" rel="nofollow noopener" target="_blank">https://www.instagram.com/justingordon8/</a>

#254: Mehdi Maghsoodnia, Founder & CEO of 1health, the Leading Testing as a Service Platform

Joe Cotela

Lotti Bluemner

LEAD

OFFICIAL SITE | FACEBOOK | INSTAGRAM | TWITTER  Knight Beauties was founded by Los Angeles based model, designer, and full-time single mother Lotti Bluemner. Knight Beauties came to life when Lotti found out music and art programs were being eliminated in schools.  She created her company because she wanted to make sure her daughter had creative outlets focusing on the arts.  Together they make eye-catching jewelry, accessories, clothes and they also give back.  Knight Beauties donates a portion of proceeds to multiple charities that help put music and art programs back into schools.   OFFICIAL SITE | YOUTUBE | FACEBOOK | TWITTER | iTunes   Rock band DED - Comprised of Joe Cotela (vocals), David Ludlow (guitar), Kyle Koelsch (bass), and Matt Reinhard (drums) – are one of rock’s most promising newcomers, and they have something to say. Their message has always been about hope, self-care, and the importance of being aware of how we look after each other and how our behavior affects not only our own mental health but each other. During this time of global pandemic and isolation, their message is even more relevant and important. The band believes that change starts with us as individuals and is building a community by offering comfort in times of despair, positivity by exposing negativity, and clarity through suffering.  DED is driven by a compassion for humanity and a consciousness that we can all be and do better.      OFFICIAL SITE | LINKEDIN | FACEBOOK | INSTAGRAM   Mehdi Maghsoodnia is the Chairman and CEO of Vitagene. He joined the company in February 2016. Maghsoodnia brings over 20 years of experience in executive management roles at both public and private companies and has deep expertise in building technology companies in new markets. Prior to Vitagene, Maghsoodnia held a number of executive positions including CEO of Rafter, SVP of CafePress, Intellisync (Acquired by Nokia), and Actiance. Maghsoodnia is also an active angel investor and board member in several early-stage startups including SpineZone, MedCorder, Turncare, Swiftly, and StrongDM. Maghsoodnia received his Bachelor of Science degree in Electrical Engineering and Computer Science from the University of California, Berkeley, and has done graduate-level studies in computer science at Stanford University.

<a href="https://knightbeauties.com/" rel="nofollow" target="_blank">OFFICIAL SITE</a> | <a href="https://www.facebook.com/knightbeauties" rel="nofollow" target="_blank">FACEBOOK </a>| <a href="https://www.instagram.com/knightbeauties/" rel="nofollow" target="_blank">INSTAGRAM</a> | <a href="https://twitter.com/knightbeauties" rel="nofollow" target="_blank">TWITTER</a> Knight Beauties was founded by Los Angeles based model, designer, and full-time single mother Lotti Bluemner. Knight Beauties came to life when Lotti found out music and art programs were being eliminated in schools.  She created her company because she wanted to make sure her daughter had creative outlets focusing on the arts.  Together they make eye-catching jewelry, accessories, clothes and they also give back.  Knight Beauties donates a portion of proceeds to multiple charities that help put music and art programs back into schools. <a href="https://www.dedband.com/" rel="nofollow" target="_blank">OFFICIAL SITE</a> | <a href="https://www.youtube.com/c/dedofficial" rel="nofollow" target="_blank">YOUTUBE</a> | <a href="https://www.facebook.com/dedofficial" rel="nofollow" target="_blank">FACEBOOK</a> | <a href="https://twitter.com/WeAreDED" rel="nofollow" target="_blank">TWITTER</a> |<a href="https://music.apple.com/us/album/mis-an-thrope/1238486219?app=itunes&amp;ign-mpt=uo%3D4" rel="nofollow" target="_blank"> iTunes</a> Rock band DED - Comprised of Joe Cotela (vocals), David Ludlow (guitar), Kyle Koelsch (bass), and Matt Reinhard (drums) – are one of rock’s most promising newcomers, and they have something to say. Their message has always been about hope, self-care, and the importance of being aware of how we look after each other and how our behavior affects not only our own mental health but each other. During this time of global pandemic and isolation, their message is even more relevant and important. The band believes that change starts with us as individuals and is building a community by offering comfort in times of despair, positivity by exposing negativity, and clarity through suffering.  DED is driven by a compassion for humanity and a consciousness that we can all be and do better.    <a href="https://vitagene.com/" rel="nofollow" target="_blank">OFFICIAL SITE</a> | <a href="https://www.linkedin.com/company/vitagene" rel="nofollow" target="_blank">LINKEDIN</a> |<a href="https://www.facebook.com/vitagene/" rel="nofollow" target="_blank"> FACEBOOK</a> |<a href="https://www.instagram.com/vitagene/" rel="nofollow" target="_blank"> INSTAGRAM</a> Mehdi Maghsoodnia is the Chairman and CEO of Vitagene. He joined the company in February 2016. Maghsoodnia brings over 20 years of experience in executive management roles at both public and private companies and has deep expertise in building technology companies in new markets. Prior to Vitagene, Maghsoodnia held a number of executive positions including CEO of Rafter, SVP of CafePress, Intellisync (Acquired by Nokia), and Actiance. Maghsoodnia is also an active angel investor and board member in several early-stage startups including SpineZone, MedCorder, Turncare, Swiftly, and StrongDM. Maghsoodnia received his Bachelor of Science degree in Electrical Engineering and Computer Science from the University of California, Berkeley, and has done graduate-level studies in computer science at Stanford University.

Lotti Bluemner CEO | Joe Cotela Lead Singer of DED | Mehdi Maghsoodnia CEO of Vitagene